Structures by: Jasinski J. P.
Total: 594
8-Bromo-1,3-diphenyl-2,3-dihydro-1<i>H</i>-naphtho[1,2-<i>e</i>][1,3]oxazine
C24H18BrNO
Acta Crystallographica Section E (2010) 66, 8 o2053-o2054
a=7.7617(11)Å b=20.092(3)Å c=11.5094(16)Å
α=90.00° β=91.893(2)° γ=90.00°
2,3-Dibromo-1,3-bis(4-fluorophenyl)propan-1-one
C15H10Br2F2O
Acta Crystallographica Section E (2010) 66, 8 o2018
a=5.7381(13)Å b=9.909(2)Å c=12.575(3)Å
α=75.324(3)° β=87.472(3)° γ=82.300(3)°
4-(4-Chlorophenyl)-4-hydroxypiperidinium maleate maleic acid solvate
C11H15ClNO,C4H3O4,C4H4O4
Acta Crystallographica Section E (2010) 66, 8 o2012-o2013
a=19.282(7)Å b=7.867(3)Å c=25.115(9)Å
α=90.00° β=91.545(5)° γ=90.00°
Opipramol dipicrate
C23H31N3O2,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 8 o1979-o1980
a=7.3838(8)Å b=12.0400(13)Å c=22.074(2)Å
α=74.8210(10)° β=84.355(2)° γ=73.866(2)°
(2<i>E</i>)-1-(3-Bromophenyl)-3-(4,5-dimethoxy-2-nitrophenyl)prop-2-en-1-one
C17H14BrNO5
Acta Crystallographica Section E (2010) 66, 11 o2936-o2937
a=6.8547(2)Å b=8.3205(2)Å c=27.1509(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>^1^,<i>N</i>^2^-Bis[(2-chloro-6-methylquinolin-3-yl)methylidene]ethane- 1,2-diamine
C24H20Cl2N4
Acta Crystallographica Section E (2010) 66, 11 o2869
a=4.4088(8)Å b=7.2008(11)Å c=16.9383(18)Å
α=84.236(11)° β=87.924(12)° γ=78.698(14)°
<i>N</i>-(Diethylcarbamothioyl)-4-nitrobenzamide
C12H15N3O3S
Acta Crystallographica Section E (2010) 66, 10 o2589
a=6.884(5)Å b=19.237(5)Å c=10.146(5)Å
α=90.000° β=92.983(5)° γ=90.000°
1-[2-(2-Bromophenyl)ethyl]-4-chloro-2-nitrobenzene
C14H11BrClNO2
Acta Crystallographica Section E (2010) 66, 12 o3358
a=15.7756(4)Å b=7.3795(2)Å c=11.5236(3)Å
α=90.00° β=90.00° γ=90.00°
Levocetirizinium dipicrate
C21H27ClN2O32,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 12 o3167
a=11.24440(10)Å b=15.7720(2)Å c=20.6204(2)Å
α=90.00° β=95.9980(10)° γ=90.00°
Orphenadrinium picrate
C18H24NO,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o190-o191
a=9.9434(10)Å b=11.2216(8)Å c=11.3523(12)Å
α=78.658(7)° β=76.342(9)° γ=87.660(7)°
2-Bromo-1-(3-nitrophenyl)ethanone
C8H6BrNO3
Acta Crystallographica Section E (2011) 67, 1 o29-o30
a=8.8259(7)Å b=8.8651(8)Å c=11.6775(8)Å
α=74.691(7)° β=75.174(7)° γ=78.681(7)°
1-(10<i>H</i>-Phenothiazin-2-yl)ethanone
C14H11NOS
Acta Crystallographica Section E (2011) 67, 2 o430-o431
a=14.3445(18)Å b=5.5425(7)Å c=15.694(2)Å
α=90.00° β=114.494(2)° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one
C15H12BrNO2
Acta Crystallographica Section E (2011) 67, 2 o352-o353
a=26.3402(13)Å b=3.8906(2)Å c=27.5826(17)Å
α=90.00° β=113.892(5)° γ=90.00°
<i>N</i>-(4-Bromophenyl)-4-nitrobenzamide
C13H9BrN2O3
Acta Crystallographica Section E (2011) 67, 2 o279
a=4.57903(6)Å b=12.92579(15)Å c=20.5614(3)Å
α=90.00° β=96.0333(11)° γ=90.00°
(2<i>E</i>)-3-[4-(Dimethylamino)phenyl]-1-(4-fluorophenyl)prop-2-en-1-one
C17H16FNO
Acta Crystallographica Section E (2011) 67, 2 o313-o314
a=12.8334(3)Å b=12.3560(2)Å c=9.3922(2)Å
α=90.00° β=105.965(2)° γ=90.00°
(<i>E</i>)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one
C17H16O4
Acta Crystallographica Section E (2011) 67, 4 o845
a=14.2315(2)Å b=8.02920(10)Å c=13.6027(2)Å
α=90.00° β=110.0531(14)° γ=90.00°
(2<i>E</i>)-3-(4-Chlorophenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one
C15H11ClO2
Acta Crystallographica Section E (2011) 67, 4 o756
a=7.3570(2)Å b=15.6450(5)Å c=10.4954(3)Å
α=90.00° β=90.518(3)° γ=90.00°
(2<i>E</i>)-3-(3,4-Dimethoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one
C17H16O4
Acta Crystallographica Section E (2011) 67, 4 o813
a=15.14350(10)Å b=8.43640(10)Å c=22.9454(2)Å
α=90.00° β=90.00° γ=90.00°
1,3-Bis(prop-2-ynyl)-1<i>H</i>-1,3-benzimidazol-2(3<i>H</i>)-one
C13H10N2O
Acta Crystallographica Section E (2011) 67, 5 o1091
a=7.7398(4)Å b=17.1869(9)Å c=8.4856(5)Å
α=90.00° β=101.459(6)° γ=90.00°
3-Fluoroanilinium 4-methylbenzenesulfonate
C6H7FN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 11 o2924
a=14.5385(7)Å b=6.4939(3)Å c=14.5522(7)Å
α=90.00° β=91.429(4)° γ=90.00°
3,3-Dimethyl-1,2,3,4-tetrahydrocyclopenta[<i>b</i>]indole-1,2-dione
C13H11NO2
Acta Crystallographica Section E (2012) 68, 2 o364-o365
a=9.1091(7)Å b=11.5337(8)Å c=11.8745(9)Å
α=63.230(7)° β=80.596(6)° γ=79.970(6)°
(2<i>E</i>)-1-(3,4-Dichlorophenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one
C15H10Cl2O2
Acta Crystallographica Section E (2012) 68, 2 o366
a=7.2551(6)Å b=7.8351(7)Å c=12.8049(11)Å
α=92.367(7)° β=102.946(8)° γ=109.011(8)°
1,3-Bis(biphenyl-4-yl)-2,2-dibromo-3-oxopropyl acetate
C29H22Br2O3
Acta Crystallographica Section E (2012) 68, 2 o362-o363
a=12.0497(14)Å b=20.842(2)Å c=9.9482(10)Å
α=90.00° β=98.743(10)° γ=90.00°
9-[3-(Dimethylamino)propyl]-2-trifluoromethyl-9<i>H</i>-thioxanthen-9-ol
C19H20F3NOS
Acta Crystallographica Section E (2011) 67, 8 o1883
a=7.6183(3)Å b=13.9605(4)Å c=17.4172(7)Å
α=90.00° β=101.053(4)° γ=90.00°
2-(4-Bromophenyl)-<i>N</i>-(pyrazin-2-yl)acetamide
C12H10BrN3O
Acta Crystallographica Section E (2013) 69, 6 o891
a=10.6804(4)Å b=7.5196(3)Å c=29.1355(10)Å
α=90° β=90° γ=90°
1-[Bis(4-fluorophenyl)methyl]-4-[(2<i>Z</i>)-3-phenylprop-2-en-1-yl]piperazine-1,4-diium dichloride monohydrate
C26H28F2N22,2(Cl),0.5(H2O)
Acta Crystallographica Section E (2014) 70, 6 o694-o695
a=18.2973(6)Å b=7.02041(14)Å c=20.1554(6)Å
α=90° β=104.601(3)° γ=90°
<i>N</i>-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)-2-(4-nitrophenyl)acetamide
C19H18N4O4
Acta Crystallographica Section E (2014) 70, 6 o636-o637
a=6.7023(6)Å b=8.6335(8)Å c=15.8720(13)Å
α=76.305(7)° β=84.399(7)° γ=77.252(7)°
Flunarizinium isonicotinate
C26H27F2N2,C6H4NO2
Acta Crystallographica Section E (2014) 70, 6 o681-o682
a=11.0023(3)Å b=10.6435(3)Å c=11.3393(3)Å
α=90° β=92.481(3)° γ=90°
Pyrimethaminium 2-{[4-(trifluoromethyl)phenyl]sulfanyl}benzoate dimethyl sulfoxide monosolvate
C12H14ClN4,C14H8F3O2S,C2H6OS
Acta Crystallographica Section E (2014) 70, 6 o683-o684
a=12.7422(3)Å b=22.2773(3)Å c=11.1761(3)Å
α=90° β=114.014(3)° γ=90°
4-pyrimidin-2-yl-piperazin-1-ium fumarate
C8H13N4,C4H3O4
Acta Crystallographica Section E (2014) 70, 6 o702-o703
a=12.3425(5)Å b=7.0365(3)Å c=14.7178(6)Å
α=90° β=94.213(3)° γ=90°
1(2-Furoyl)piperazinium 3,5-dinitrobenzoate
C9H13N2O2,C7H3N2O6
Acta Crystallographica Section E (2014) 70, 6 o700-o701
a=9.6060(2)Å b=10.4572(2)Å c=33.8766(7)Å
α=90° β=90° γ=90°
2,2-Diphenyl-4-(piperidin-1-yl)butanamide
C21H26N2O
Acta Crystallographica Section E (2011) 67, 7 o1827
a=18.1070(12)Å b=10.3025(9)Å c=9.6150(6)Å
α=90.00° β=90.00° γ=90.00°
7-Methoxy-3,4-dihydronaphthalen-1(2<i>H</i>)-one
C11H12O2
Acta Crystallographica Section E (2011) 67, 7 o1646
a=7.4303(4)Å b=7.4614(4)Å c=16.4393(8)Å
α=90.00° β=90.976(4)° γ=90.00°
4-Chloroanilinium 4-methylbenzenesulfonate
C6H7ClN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 12 o3288-o3289
a=5.7253(5)Å b=7.5160(6)Å c=15.7642(13)Å
α=95.166(6)° β=96.148(7)° γ=92.353(7)°
Ethyl 2-amino-4,6-bis(4-fluorophenyl)cyclohexa-1,3-diene-1-carboxylate
C21H19F2NO2
Acta Crystallographica Section E (2012) 68, 3 o585
a=18.0199(5)Å b=9.6391(2)Å c=21.0754(7)Å
α=90.00° β=90.00° γ=90.00°
4-Methylphenyl quinoline-2-carboxylate
C17H13NO2
Acta Crystallographica Section E (2012) 68, 11 o3231-o3232
a=11.5421(2)Å b=17.3191(3)Å c=26.6667(5)Å
α=90.00° β=90.00° γ=90.00°
3,3-dimethyl-1<i>H</i>,4<i>H</i>-cyclopenta[<i>b</i>]indol-2(3<i>H</i>)-one
C13H13NO
Acta Crystallographica Section E (2013) 69, 7 o1043
a=10.13410(14)Å b=21.9219(3)Å c=19.3747(3)Å
α=90° β=90° γ=90°
Ethyl 2-amino-6-(4-bromophenyl)-4-(4-fluorophenyl)cyclohexa-1,3-diene-1-carboxylate
C21H19BrFNO2
Acta Crystallographica Section E (2013) 69, 9 o1473
a=9.4599(2)Å b=23.3634(5)Å c=17.2312(4)Å
α=90° β=96.001(2)° γ=90°
3-Amino-1<i>H</i>-pyrazol-2-ium trifluoroacetate
C3H6N3,C2F3O2
Acta Crystallographica Section E (2013) 69, 9 o1425-o1426
a=10.9292(8)Å b=10.9332(6)Å c=13.7002(13)Å
α=90° β=107.939(9)° γ=90°
4-Hydroxy-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-6(5<i>H</i>)-one dihydrate
C15H12N4O4,2(H2O)
Acta Crystallographica Section E (2013) 69, 11 o1707-o1708
a=9.5817(3)Å b=13.9439(3)Å c=12.4804(4)Å
α=90° β=109.832(3)° γ=90°
Bis-[1-(benzo[1,3]dioxol-5-yl-methyl)piperazinyl]methane
C25H32N4O4
Acta Crystallographica Section E (2013) 69, 11 o1669
a=38.8025(10)Å b=9.7675(2)Å c=6.09571(13)Å
α=90° β=90° γ=90°
<i>N</i>-(1,3-Benzothiazol-2-yl)acetamide
C9H8N2OS
Acta Crystallographica Section E (2013) 69, 11 o1622
a=11.1852(4)Å b=7.4037(4)Å c=20.9189(8)Å
α=90° β=94.408(3)° γ=90°
2-[4-(Trifluoromethyl)phenylsulfanyl]benzoic acid
C14H9F3O2S
Acta Crystallographica Section E (2013) 69, 11 o1704
a=7.3071(5)Å b=8.0790(7)Å c=11.3878(11)Å
α=82.678(8)° β=83.642(7)° γ=72.309(7)°
<i>N</i>-(1<i>H</i>-Indol-3-ylmethylidene)-4-methylpiperazin-1-amine
C14H18N4
Acta Crystallographica Section E (2013) 69, 11 o1706
a=7.5630(5)Å b=6.5593(4)Å c=13.2319(9)Å
α=90° β=100.072(6)° γ=90°
1-[4-(4-Hydroxyphenyl)piperazin-1-yl]ethanone
C12H16N2O2
Acta Crystallographica Section E (2013) 69, 11 o1671
a=6.13183(19)Å b=12.0106(4)Å c=14.8704(5)Å
α=90° β=94.025(3)° γ=90°
(2<i>E</i>)-1-(4-Chlorophenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one
C18H17ClO
Acta Crystallographica Section E (2014) 70, 8 o855
a=8.8547(5)Å b=5.8455(3)Å c=28.8034(17)Å
α=90° β=97.396(6)° γ=90°
3,4-Dimethylphenyl quinoline-2-carboxylate
C18H15NO2
Acta Crystallographica Section E (2013) 69, 12 o1853-o1854
a=6.19172(17)Å b=15.4196(4)Å c=14.6585(4)Å
α=90° β=90.761(3)° γ=90°
Raltegravir monohydrate
C20H21FN6O5,H2O
Acta Crystallographica Section E (2013) 69, 12 o1743-o1744
a=8.3860(6)Å b=11.8610(9)Å c=12.1102(9)Å
α=110.481(7)° β=108.093(7)° γ=92.329(6)°
1-Piperonylpiperazinium picrate
C12H17N2O2,C6H2N3O7
Acta Crystallographica Section E (2014) 70, 2 o208-o209
a=12.0864(2)Å b=6.96981(11)Å c=23.4898(4)Å
α=90° β=96.5141(17)° γ=90°
1H-imidazole
C19H19FN2
Acta Crystallographica Section E (2011) 67, 5 o1065
a=8.4226(10)Å b=9.5572(10)Å c=11.0351(11)Å
α=105.423(9)° β=105.677(9)° γ=95.781(9)°
(<i>E</i>)-1-(2,4-Dinitrophenyl)-2-(2-fluorobenzylidene)hydrazine
C13H9FN4O4
Acta Crystallographica Section E (2011) 67, 5 o1200-o1201
a=7.0961(8)Å b=8.2714(9)Å c=11.7230(8)Å
α=88.614(7)° β=80.544(8)° γ=71.368(10)°
(6<i>Z</i>)-3,5-Bis(4-fluorophenyl)-6-(1-hydroxyethylidene)cyclohex-2-en-1-one
C20H16F2O2
Acta Crystallographica Section E (2012) 68, 3 o638-o639
a=17.663(2)Å b=6.2371(6)Å c=15.2357(16)Å
α=90.00° β=107.717(13)° γ=90.00°
1-Benzoyl-3-(naphthalen-1-yl)thiourea
C18H14N2OS
Acta Crystallographica Section E (2011) 67, 12 o3187
a=9.7368(14)Å b=5.2256(10)Å c=28.619(4)Å
α=90.00° β=92.126(12)° γ=90.00°
Trimethylammonium dichloridotriphenylstannate(IV)
C18H15Cl2Sn,C3H10N
Acta Crystallographica Section E (2012) 68, 10 m1279
a=9.2650(2)Å b=15.6882(4)Å c=14.7891(3)Å
α=90.00° β=90.941(2)° γ=90.00°
(2,4-Difluorobenzoyl)[bis(pyrrolidin-1-yl)phosphoryl]amine
C15H20F2N3O2P
Acta Crystallographica Section E (2012) 68, 9 o2688
a=9.1028(3)Å b=9.9477(2)Å c=18.5465(5)Å
α=90.00° β=92.268(3)° γ=90.00°
(+-)-(4b<i>S</i>,8a<i>R</i>,10a<i>S</i>)-10a-Ethynyl-4b,8,8-trimethyl-3,7- dioxo-3,4b,7,8,8a,9,10,10a-octahydrophenanthrene-2,6-dicarbonitrile
C21H18N2O2
Acta Crystallographica Section E (2012) 68, 11 o3095-o3096
a=7.3012(2)Å b=12.9843(3)Å c=18.4254(4)Å
α=95.051(2)° β=96.284(2)° γ=92.338(2)°
3-(4-Fluorophenyl)-1<i>H</i>-pyrazole--5-(4-fluorophenyl)-1<i>H</i>-pyrazole (1/1)
C9H7FN2
Acta Crystallographica Section E (2014) 70, 9 o949-o950
a=10.3961(5)Å b=10.8565(6)Å c=16.1431(7)Å
α=84.704(4)° β=76.223(4)° γ=68.249(5)°
<i>N</i>-(3-Benzoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)benzamide
C22H19NO2S
Acta Crystallographica Section E (2014) 70, 9 o951-o952
a=13.5223(4)Å b=6.23222(15)Å c=22.2941(6)Å
α=90° β=106.150(3)° γ=90°
Opipramolium fumarate
C23H30N3O,C4H3O4
Acta Crystallographica Section E (2011) 67, 9 o2296
a=8.9116(3)Å b=6.7167(3)Å c=20.6377(8)Å
α=90.00° β=98.685(3)° γ=90.00°
9,9-Dimethyl-9,10-dihydroanthracene
C16H16
Acta Crystallographica Section E (2011) 67, 9 o2397
a=12.7042(15)Å b=7.4882(7)Å c=13.177(2)Å
α=90.00° β=107.787(14)° γ=90.00°
5-(Biphenyl-4-yl)-3-(3-methoxybenzylidene)furan-2(3<i>H</i>)-one
C24H18O3
Acta Crystallographica Section E (2011) 67, 9 o2294-o2295
a=19.8766(8)Å b=6.9914(3)Å c=13.2603(6)Å
α=90.00° β=107.735(4)° γ=90.00°
Methyl 3,5-dibromo-2-diacetylaminobenzoate
C12H11Br2NO4
Acta Crystallographica Section E (2011) 67, 9 o2503
a=7.6386(8)Å b=8.8870(6)Å c=10.8691(8)Å
α=78.186(6)° β=76.155(7)° γ=82.750(7)°
Tramadol hydrochloride-Benzoic acid (1/1)
C16H26NO2,Cl,C7H6O2
Acta Crystallographica Section E (2011) 67, 9 o2351
a=8.9721(2)Å b=10.4086(2)Å c=12.5189(3)Å
α=90.00° β=101.646(2)° γ=90.00°
2,3-dihydropyrazine
C23H19ClN2
Acta Crystallographica Section E (2011) 67, 10 o2598
a=10.5675(8)Å b=19.7014(9)Å c=10.4207(7)Å
α=90° β=118.479(9)° γ=90°
Di-μ-bromido-bis{[<i>N</i>,<i>N</i>-dimethyl-<i>N</i>-(thiophen-2- ylmethylidene)ethane-1,2-diamine]copper(I)]}
C18H28Br2Cu2N4S2
Acta Crystallographica Section E (2012) 68, 5 m691-m692
a=10.2029(3)Å b=15.4175(3)Å c=8.04875(19)Å
α=90.00° β=108.628(3)° γ=90.00°
2,5-dimethylphenyl quinoline-2-carboxylate
C18H15NO2
Acta Crystallographica Section E (2014) 70, 2 o147
a=8.2261(3)Å b=11.6007(5)Å c=14.5738(5)Å
α=90° β=90° γ=90°
Flupentixol tartrate
C23H26F3N2OS,C4H5O6
Acta Crystallographica Section E (2014) 70, 2 o206-o207
a=9.9239(3)Å b=9.1968(3)Å c=30.0099(8)Å
α=90° β=96.617(3)° γ=90°
5-Aminopyrazol-2-ium hydrogen succinate
C3H6N3,C4H5O4
Acta Crystallographica Section E (2014) 70, 2 o221-o222
a=18.525(3)Å b=6.7872(9)Å c=14.564(3)Å
α=90° β=108.900(18)° γ=90°
Enrofloxacinium oxalate
2(C19H23FN3O3),C2O42
Acta Crystallographica Section E (2014) 70, 2 o200-o201
a=9.8552(5)Å b=13.3056(8)Å c=15.6124(8)Å
α=68.987(5)° β=84.740(4)° γ=73.093(5)°
{2-[1-(2-Methoxy-6-oxidophenyl-κ<i>O</i>^6^)ethylidene]-<i>N</i>-methylhydrazinecarbothioamidato-κ^2^<i>N</i>^2^,<i>S</i>}(triphenylphosphane-κ<i>P</i>)palladium(II) ethanol monosolvate
C29H28N3O2PPdS,C2H6O
Acta Crystallographica Section E (2013) 69, 10 m528-m529
a=8.0294(6)Å b=12.0187(6)Å c=16.2151(8)Å
α=105.764(4)° β=100.835(5)° γ=94.965(5)°
[2-(1-Hydroxycyclohexyl)-2-(4-hydroxyphenyl)ethyl]dimethylammonium chloranilate ethyl acetate
C16H26NO2,C6HCl2O4,C4H8O2
Acta Crystallographica Section E (2013) 69, 10 o1556-o1557
a=11.1738(2)Å b=9.39846(16)Å c=13.6046(2)Å
α=90.00° β=105.109(2)° γ=90.00°
3-(1<i>H</i>-Imidazol-1-yl)propanaminium picrate
C6H2N3O7,C6H12N3
Acta Crystallographica Section E (2013) 69, 10 o1572-o1573
a=11.98275(18)Å b=38.5234(6)Å c=16.4239(2)Å
α=90° β=94.1970(14)° γ=90°
6-(3-Chlorophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C10H6ClN3S
Acta Crystallographica Section E (2013) 69, 1 o66
a=5.43804(19)Å b=12.4222(4)Å c=14.1684(4)Å
α=90.00° β=100.269(3)° γ=90.00°
Diphenylmethyl benzoate
C20H16O2
Acta Crystallographica Section E (2013) 69, 1 o81
a=5.75357(19)Å b=16.0368(5)Å c=8.3114(3)Å
α=90.0° β=95.340(3)° γ=90.0°
2-[1-(2-Hydroxy-6-methoxyphenyl)ethylidene]-<i>N</i>- methylhydrazinecarbothioamide acetonitrile monosolvate
C11H15N3O2S,C2H3N
Acta Crystallographica Section E (2013) 69, 1 o11
a=7.6232(10)Å b=9.4004(9)Å c=11.8031(12)Å
α=80.121(8)° β=71.555(10)° γ=74.732(10)°
4-<i>tert</i>-butyl-<i>N</i>-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)- 2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide monohydrate
C27H29N5O6S,H2O
Acta Crystallographica Section E (2013) 69, 1 o12-o13
a=12.3393(4)Å b=15.1238(6)Å c=14.6988(4)Å
α=90.00° β=95.037(3)° γ=90.00°
4-Diphenylmethyl-1-[(<i>E</i>)-3-phenylprop-2-en-1-yl]piperazin-1-ium (2<i>Z</i>)-3-carboxyprop-2-enoate
C26H29N2,C4H3O4
Acta Crystallographica Section E (2013) 69, 1 o142-o143
a=21.9467(4)Å b=10.43729(18)Å c=11.20623(19)Å
α=90.00° β=90.0458(15)° γ=90.00°
2-Methyl-4-(4-methylpiperazin-4-ium-1-yl)-10<i>H</i>- thieno[2,3-<i>b</i>][1,5]benzodiazepinium bis(2,4,6-trinitrophenolate)
C17H22N4S2,2(C6H2N3O7)
Acta Crystallographica Section E (2013) 69, 2 o232-o233
a=22.1660(4)Å b=12.7349(2)Å c=23.3951(4)Å
α=90.00° β=90.00° γ=90.00°
{2-[(4-Nitrobenzylidene)amino]-4,5,6,7-tetrahydro-1-benzothiophen-3-yl}(phenyl)methanone
C22H18N2O3S
Acta Crystallographica Section E (2014) 70, 6 o738-o739
a=4.61595(13)Å b=17.6844(4)Å c=11.7068(3)Å
α=90° β=91.285(3)° γ=90°
4-[(<i>E</i>)-(4-Hydroxybenzylidene)amino]-3-methyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C10H10N4OS
Acta Crystallographica Section E (2014) 70, 6 o733-o734
a=5.7677(5)Å b=7.7233(8)Å c=12.7269(12)Å
α=84.104(8)° β=77.719(8)° γ=73.358(9)°
4-acetylpiperazinium picrate
C6H13N2O,C6H2N3O7
Acta Crystallographica Section E (2014) 70, 6 o717-o718
a=6.6843(7)Å b=11.5971(12)Å c=20.131(2)Å
α=90° β=90.000(4)° γ=90°
<i>N</i>-Ethyl-2-[1-(2-hydroxy-4-methylphenyl)ethylidene]hydrazinecarbothioamide
C12H17N3OS
Acta Crystallographica Section E (2014) 70, 6 o735
a=7.4253(4)Å b=8.7713(4)Å c=20.7093(11)Å
α=96.238(4)° β=94.400(5)° γ=100.177(4)°
3-(4-Fluorobenzoyl)-4-(4-fluorophenyl)-4-hydroxy-2,6-diphenylcyclohexane-1,1-dicarbonitrile
C33H24F2N2O2
Acta Crystallographica Section E (2014) 70, 6 o736-o737
a=10.9336(10)Å b=11.5258(4)Å c=11.8490(7)Å
α=89.440(4)° β=62.687(7)° γ=89.296(5)°
<i>N</i>-Ethyl-2-[1-(2-hydroxynaphthalen-1-yl)ethylidene]hydrazinecarbothioamide
C15H17N3OS
Acta Crystallographica Section E (2014) 70, 6 o732
a=8.8988(7)Å b=9.2993(8)Å c=9.4821(5)Å
α=92.525(6)° β=113.034(7)° γ=93.990(7)°
2-(2-Methylphenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C12H12N2OS
Acta Crystallographica Section E (2014) 70, 6 o716
a=17.6983(6)Å b=4.94078(13)Å c=14.4603(5)Å
α=90° β=111.236(4)° γ=90°
4-[(4-Acetylphenyl)amino]-2-methylidene-4-oxobutanoic acid
C13H13NO4
Acta Crystallographica Section E (2014) 70, 7 o752-o753
a=5.0164(5)Å b=5.2908(4)Å c=21.8464(18)Å
α=92.833(6)° β=90.315(7)° γ=96.222(7)°
1-{3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]-4,5-dihydro-1<i>H</i>-pyrazol-1-yl}butan-1-one
C22H25ClN2O
Acta Crystallographica Section E (2014) 70, 7 o761-o762
a=6.8148(6)Å b=11.1115(9)Å c=13.8239(15)Å
α=70.935(9)° β=81.420(8)° γ=75.829(7)°
1-{3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]-4,5-dihydro-1<i>H</i>-pyrazol-1-yl}propan-1-one
C21H23ClN2O
Acta Crystallographica Section E (2014) 70, 7 o763-o764
a=6.6042(3)Å b=10.1188(9)Å c=14.4806(12)Å
α=98.444(7)° β=90.650(6)° γ=106.542(6)°
4-[(4-Bromophenyl)amino]-2-methylidene-4-oxobutanoic acid
C11H10BrNO3
Acta Crystallographica Section E (2014) 70, 7 o779-o780
a=6.2782(4)Å b=8.3251(5)Å c=21.3244(12)Å
α=96.462(5)° β=92.026(5)° γ=95.390(5)°
1-{3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]-4,5-dihydro-1<i>H</i>-pyrazol-1-yl}ethanone
C20H21ClN2O
Acta Crystallographica Section E (2014) 70, 7 o781
a=6.4836(6)Å b=9.6524(9)Å c=14.4390(10)Å
α=81.178(7)° β=89.720(7)° γ=77.488(8)°
4-(4-Chlorophenyl)-4-hydroxypiperidinium benzoate
C11H15ClNO,C7H5O2
Acta Crystallographica Section E (2011) 67, 6 o1436
a=9.6235(12)Å b=10.0971(16)Å c=10.2251(14)Å
α=99.608(12)° β=108.748(13)° γ=113.357(14)°
(1<i>E</i>,2<i>E</i>)-1,2-Bis(3-bromo-4-methoxybenzylidene)hydrazine
C16H14Br2N2O2
Acta Crystallographica Section E (2011) 67, 6 o1379
a=10.1354(8)Å b=10.5500(10)Å c=15.6055(12)Å
α=90.00° β=96.680(7)° γ=90.00°
<i>N</i>-(3-Chloro-4-fluorophenyl)-2-(naphthalen-1-yl)acetamide
C18H13ClFNO
Acta Crystallographica Section E (2011) 67, 7 o1826
a=8.096(6)Å b=23.323(6)Å c=8.404(3)Å
α=90.00° β=110.83(5)° γ=90.00°
3-(5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5-ylidene)- <i>N</i>,<i>N</i>-dimethylpropanaminium chloride
C20H22N,Cl
Acta Crystallographica Section E (2011) 67, 7 o1846
a=32.0959(7)Å b=32.0959(7)Å c=13.7578(5)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Methylphenyl)benzonitrile
C14H11N
Acta Crystallographica Section E (2011) 67, 7 o1647
a=7.6726(4)Å b=11.4037(5)Å c=12.2426(5)Å
α=90.00° β=90.00° γ=90.00°
1-(5,5-Dioxido-10<i>H</i>-phenothiazin-10-yl)ethanone
C14H11NO3S
Acta Crystallographica Section E (2011) 67, 7 o1702
a=12.5715(6)Å b=8.7648(4)Å c=11.5828(5)Å
α=90.00° β=92.142(4)° γ=90.00°
Methyl 2-(4-hydroxybenzoyl)benzoate
C15H12O4
Acta Crystallographica Section E (2011) 67, 8 o1994
a=8.9017(12)Å b=13.9940(17)Å c=10.0473(12)Å
α=90.00° β=94.687(12)° γ=90.00°
1H-imidazole
C25H15FN4,H2O
Acta Crystallographica Section E (2011) 67, 8 o1965
a=9.0103(10)Å b=10.0946(9)Å c=11.3994(9)Å
α=86.987(7)° β=75.950(8)° γ=82.396(8)°
2,2-Diphenylacetamide
C14H13NO
Acta Crystallographica Section E (2011) 67, 8 o1992-o1993
a=5.1687(3)Å b=28.5511(13)Å c=7.8006(4)Å
α=90.00° β=98.152(5)° γ=90.00°
4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)-3-methoxybenzaldehyde tetrahydrate
C16H14N2O3,4(H2O)
Acta Crystallographica Section E (2011) 67, 8 o2021-o2022
a=6.8953(6)Å b=11.4266(13)Å c=11.7287(14)Å
α=107.965(10)° β=90.906(8)° γ=91.769(8)°